[image_with_animation image_url=”9189″ animation=”Fade In” hover_animation=”none” alignment=”center” img_link_target=”_blank” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default” img_link=”https://www.mednous.com/news/fda-approves-first-faecal-microbiota-product”]Hervé Affagard, CEO and co-founder of MaaT Pharma, commented on the first FDA-approval for a microbiome therapy.